VBIO logo

Valion Bio, Inc.

VBIO
Healthcare|Biotechnology|US
$0.51
+0.01 (+1.57%)
DCF Value
$5.14
Tangible Book / Share
$45.75
Cash / Share
$15.59

Ownership Breakdown

99.7%
Float
2.2M
Shares Outstanding
2.1M
Float Shares

Major Holders (3)

Combined: 29.7%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
3i, LPPartnership9.90%132,671Sep 4, 202613D/G
3i Management LLCOther9.90%132,671Sep 3, 202613D/G
Maier J. TarlowIndividual9.90%132,671Sep 3, 202613D/G

Insider Trades (12)

Last 4 quarters: 278,302 acquired · 2,304 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Zikria Deandirector, officer: Interim CEOSep 22, 2026AWARD50,000——Form 4
Wolf Lisa GCOO & CFOSep 18, 2026OPTION EX.4——Form 4
Wolf Lisa GCOO & CFOSep 18, 2026TAX W/H2$2.12$4.24Form 4
Wolf Lisa GCOO & CFOSep 18, 2026OPTION EX.4——Form 4
Malbin Jared Daviddirector: Aug 27, 2026OTHER0——Form 4
Jensen Thomasdirector: Aug 27, 2026OTHER0——Form 4
Wolf Lisa GChief Financial OfficerJun 18, 2026OPTION EX.92——Form 4
Wolf Lisa GChief Financial OfficerJun 18, 2026OPTION EX.92——Form 4
Handley Michael Kdirector, officer: Chief Executive OfficerMay 18, 2026OPTION EX.2,206——Form 4
Handley Michael Kdirector, officer: Chief Executive OfficerMay 18, 2026OPTION EX.2,206——Form 4
Lackey MelindaGeneral Counsel & SVP of LegalMay 1, 2026AWARD45,000$0.96$43.2KForm 4
Lackey MelindaofficerMay 1, 2026OTHER0——Form 4